MANDY DOBROWOLSKI: Open Payments
NPI 1780357897 · CANYON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,121 in 95 payments from 31 companies in 2025. Trend: 2023 $1,143 · 2024 $1,734 · 2025 $2,121
Food & beverage: $2,121
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 12 | $238 |
| Biogen, Inc. | 10 | $190 |
| EMD Serono, Inc. | 7 | $184 |
| Eisai Inc. | 6 | $178 |
| Neurocrine BioSciences, Inc. | 6 | $130 |
| Novo Nordisk Inc | 1 | $121 |
| Janssen Biotech, Inc. | 5 | $97 |
| Alexion Pharmaceuticals, Inc. | 4 | $94 |
| ARGENX US, INC. | 4 | $89 |
| QOL Medical, LLC | 4 | $87 |
Products named: Leqembi, INGREZZA, VUMERITY, Briviact, Wegovy, ULTOMIRIS, VYVGART HYTRULO, Sucraid.
Industry payments across TX — which companies pay providers there.
